The Global Genetic Testing Market is poised to grow at a CAGR of around 10.4% over the next decade to reach approximately $10.3 billion by 2025. Some of the prominent trends that the market is witnessing include increasing prevalence of infectious, chronic, and genetic diseases, rising market for personalized medicine, and encouraging legislative & regulatory policies.
On basis of test type the market is segmented by predictive & presymptomatic testing, diagnostic testing, carrier testing, prenatal testing, and new born screening.
By diseases the market is classified into thalassemia, sickle cell anemia, alzheimer's diseases, duchenne's muscular dystrophy, huntington’s disease, cancer, cystic fibrosis, and other diseases.
Depending on the technology the market is segregated molecular testing, cytogenetic testing, and biochemical testing.
Based on application the market is categorized into cancer genetic testing, prenatal genetic testing, filling and capping machinery, pharmacogenomics genetic testing, and predisposition cancer genetic testing
This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
This report provides data tables, includes charts and graphs for visual analysis.
Regional Analysis: North America - US - Canada - Mexico
Europe - France - Germany - Italy - Spain - UK - Rest of Europe
Asia Pacific - China - Japan - India - Australia - New Zealand - Rest of Asia
Middle East - Saudi Arabia - UAE - Rest of Middle East
Latin America - Argentina - Brazil - Rest of Latin America
Rest of the World - Africa - Caribbean
Report Highlights: - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments
Our reports have been used by over 10K customers, including:
The global liquid biopsy market is expected to reach nearly US$ 6.5 Billion by 2026. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...
The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market. The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. The molecular quality controls...
2018 Global Nucleic Acid Testing (NAT) Market: Supplier Country Shares and Strategic Assessments of Key Players This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative...
2019 Global Nucleic Acid Testing/NAT Market: Supplier Shares by Country, Emerging Technologies and Strategic Profiles of Leading Suppliers This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA...
316 pages •
By Global Industry Analysts
• Jan 2019
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis...
This report provides a worldwide overview of the nucleic acid testing market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of nucleic acid testing products...
2018 Global Molecular Diagnostics Market: Supplier Country Shares and Strategic Assessments of Key Players The report presents insightful analyses of major current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products...
Global animal genetics market is projected to grow at a CAGR of 6.5% The global animal genetics market is projected to reach USD 5.8 billion by 2023 from USD 4.2 billion in 2018, at a CAGR of 6.5 % during the forecast period. Factors such as rising consumption for animal-derived protein, growing population and rapid urbanization...
Report Synopsis Emergence of novel next generation sequencing technologies, extensive use of next generation sequencing technologies in clinical diagnostics, application of sequencing technologies in cancer to detect mutations are some of the factors fueling the growth of sequencing technologies usage in the molecular diagnostics...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.